Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Curcumin Combined with Flaxseed Oil Modulates Lipid Metabolism in Hamsters Fed a High-Fat, High-Cholesterol Diet: Insights from Lipidomics.

Nutrients·2026

Same author

Evaluation of the deeplex Myc-TB-targeted next-generation sequencing assay for mycobacterial identification and drug resistance detection.

Journal of clinical microbiology·2026

Same author

Hydroxyflavone-Modified Aza-BODIPY Derivatives for Combined Photodynamic and CO Therapy against Neuroblastoma.

Journal of medicinal chemistry·2026

Same author

FOXP-stabilization of the <i>Il2ra</i> super-enhancer structure augments Treg fitness.

bioRxiv : the preprint server for biology·2026

Same author

Burden and Health System Challenges in MASLD Across East and Southeast Asia: A Narrative Review.

Health science reports·2026

Same author

A response on a critical commentary on "Prevalence of post-COVID symptoms across variants of concern and follow-up periods: a systematic review and meta-analysis".

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026

Search research articles

Related Experiment Video

Updated: Jun 9, 2025

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

Insights into Metabolic Reprogramming in Tumor Evolution and Therapy.

Ching-Feng Chiu^1,2, Jonathan Jaime G Guerrero^1,3,4, Ric Ryan H Regalado⁵

¹Graduate Institute of Metabolism and Obesity Sciences, Taipei Medical University, Taipei 110301, Taiwan.

|October 26, 2024

Summary

Cancer cells reprogram their metabolism, similar to dark matter and dark energy, offering new therapeutic targets. Understanding these metabolic shifts is key to developing innovative cancer treatments.

Keywords:

Warburg effect cancer metabolic reprogramming

More Related Videos

Assessment of the Metabolic Profile of Primary Leukemia Cells

Published on: November 21, 2018

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

Related Experiment Videos

Last Updated: Jun 9, 2025

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

Assessment of the Metabolic Profile of Primary Leukemia Cells

Published on: November 21, 2018

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

Area of Science:

Oncology
Metabolic Biology
Cosmology

Background:

Cancer is a global health challenge involving uncontrolled cell proliferation.
Cancer development and progression are linked to complex metabolic reprogramming.
Metabolic alterations are pivotal yet often overlooked in tumor evolution.

Purpose of the Study:

To review the relationship between cancer and metabolic alterations.
To compare cancer metabolism to cosmological concepts of dark matter and dark energy.
To highlight the role of metabolic reprogramming in tumor evolution.

Main Methods:

Scrutinizing the Warburg effect and other metabolic adaptations.
Examining shifts in lipid synthesis, amino acid turnover, and mitochondrial function.
Investigating metabolic changes driven by key gene mutations.

Main Results:

Metabolic reprogramming is significant in cancer development and progression.
Targeting cancer metabolic pathways offers therapeutic potential.
Disrupting cancer's energy supply and signaling is a promising strategy.

Conclusions:

Cancer's metabolic complexity can be likened to dark matter and dark energy.
Innovative strategies are needed to target cancer's metabolic "dark energy".
Understanding and targeting cancer metabolism is a promising frontier for effective treatments.